The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Neoplasms; Pyrimidines; Adolescent; Child; Child, Preschool; Infant; Female; Male; Young Adult; Phosphatidylinositol 3-Kinases; TOR Serine-Threonine Kinases
PubMed ID
39298693
PubMed Central ID
PMC11581706
Added to directory
Source checked

Report a correction or request removal